Russia: Mental Health Crisis – Depression & Anxiety Rates Soar

A significant rise in diagnosed mental health conditions is being observed in Russia, alongside a surge in antidepressant sales. Recent data indicates a growing need for mental health support within the country, with potential economic implications for the pharmaceutical sector.

Rising Diagnoses and the State of Mental Health

Between 2020 and 2024, diagnoses of depression, anxiety, or stress increased by 21.5% in Russia, according to data from the Russian Federal Statistics Agency, Rosstat. The total number of people diagnosed with non-psychotic mental disorders has risen from 281,000 to 341,400 over the same four-year period. A Russian economic daily reports that “the dynamic does not weaken.”

Antidepressant Sales Reflect Growing Need

While official data for 2025 is not yet available, the increasing sales of antidepressants provide a strong indicator of the ongoing trend. Last year, Russian pharmacies sold 23.6 million boxes of antidepressants, a 24% increase from the previous year and nearly double the amount sold in 2022.

Did You Know? In the first two weeks of January 2026, approximately one million boxes of antidepressants were sold in Russian pharmacies.

This trend continued into the new year, with sales during the first two weeks of January 2026 already showing an 18% increase compared to the same period last year.

Economic Impact of Increased Demand

The increased demand for antidepressants is also impacting the pharmaceutical market. According to DSM Group, a market analysis firm, pharmacies earned 20.5 billion rubles – approximately 226 million euros – from these sales.

Expert Insight: The substantial increase in both diagnosed mental health conditions and antidepressant sales suggests a growing, unmet need for mental healthcare services in Russia. The economic impact on the pharmaceutical industry highlights the scale of this issue and the potential for continued growth in this sector.

The data suggests a sustained increase in mental health challenges within the country.

Frequently Asked Questions

What period did diagnoses of depression, anxiety, or stress increase?

Diagnoses of depression, anxiety, or stress increased by 21.5% in Russia between 2020 and 2024.

How many boxes of antidepressants were sold in Russian pharmacies last year?

Last year, 23.6 million boxes of antidepressants were sold in Russian pharmacies.

How much revenue did pharmacies earn from antidepressant sales?

Pharmacies earned 20.5 billion rubles, or approximately 226 million euros, from antidepressant sales.

What factors might be contributing to the observed increase in mental health concerns?